Burden of Diabetes Mellitus in Nepal: An Analysis of Global Burden of Disease Study 2019.


Journal

Journal of diabetes research
ISSN: 2314-6753
Titre abrégé: J Diabetes Res
Pays: England
ID NLM: 101605237

Informations de publication

Date de publication:
2022
Historique:
received: 09 05 2022
revised: 03 12 2022
accepted: 10 12 2022
entrez: 30 12 2022
pubmed: 31 12 2022
medline: 3 1 2023
Statut: epublish

Résumé

Globally, the number of people living with diabetes mellitus (DM) increased by 62% between 1990 and 2019, affecting 463 million people in 2019, and is projected to increase further by 51% by 2045. The increasing burden of DM that requires chronic care could have a considerable cost implication in the health system, particularly in resource constraint settings like Nepal. In this context, this study attempts to present the burden of DM in terms of prevalence, mortality, and disability adjusted life years (DALYs). The study is based on the Global Burden of Disease Study 2019, a multinational collaborative research, led by the Institute for Health Metrics and Evaluations. In the study, the overall prevalence of DM was estimated using DisMod MR-2.1, a Bayesian metaregression model. DALYs were estimated summing years of life lost due to premature death and years lived with disability. There were a total of 1,412,180 prevalent cases of DM, 3,474 deaths and 189,727 DALYs, due to DM in 2019. All-age prevalence rate and the age-standardized prevalence rate of DM stood at 4,642.83 (95% uncertainty interval (UI): 4,178.58-5,137.74) and 5,735.58 (95% UI: 5,168.74-6327.73) cases per 100,000 population, respectively, in 2019. In 2019, 1.8% (95% UI: 1.54, 2.07) of total deaths were from DM, which is a more than three-fold increase from the proportion of deaths attributed in 1990 (0.43%, 95% UI: 0.36, 0.5) with most of these deaths being from DM type 2. In 2019, a total of 189,727 disability adjusted life years (DALYs) were attributable to DM of which 105,950 DALYs were among males, and the remaining 83,777 DALYs were among females. Overall, between 1990 and 2019, the DALYs, attributable to Type 1 and 2 DM combined and for Type 2 DM only, have increased gradually across both sexes. However, the DALYs per 100,000 attributable to DM have slightly reduced across both sexes in that time. There is a high burden of DM in Nepal in 2019 with a steep increase in the proportion of deaths attributable to DM in Nepal which could pose a serious challenge to the health system. Primary prevention of DM requires collaborative efforts from multiple sectors. Meanwhile, the current federal structure could be an opportunity for integrated, locally tailored public health and clinical interventions for the prevention of the disease and its consequences.

Identifiants

pubmed: 36582811
doi: 10.1155/2022/4701796
pmc: PMC9794432
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4701796

Informations de copyright

Copyright © 2022 Achyut Raj Pandey et al.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest regarding the publication of this article.

Références

Int J Obes Relat Metab Disord. 2004 Jul;28(7):858-69
pubmed: 15170463
Global Health. 2019 Apr 27;15(1):32
pubmed: 31029156
JAMA Intern Med. 2016 Nov 1;176(11):1610-1618
pubmed: 27653735
JNMA J Nepal Med Assoc. 2017 Apr-Jun;56(206):281-287
pubmed: 28746331
Prim Care Diabetes. 2016 Feb;10(1):75-82
pubmed: 26150327
Front Endocrinol (Lausanne). 2020 Aug 13;11:518
pubmed: 32903709
Curr Diab Rep. 2015 Apr;15(4):20
pubmed: 25721248
Public Health. 2021 Feb;191:59-67
pubmed: 33517247
Am J Prev Med. 2006 Nov;31(5):391-8
pubmed: 17046410
JNMA J Nepal Med Assoc. 2013 Apr-Jun;52(190):343-8
pubmed: 24362657
Public Health Nutr. 2013 Dec;16(12):2197-204
pubmed: 23308400
BMC Public Health. 2009 Jun 12;9:184
pubmed: 19523212
Asia Pac J Clin Nutr. 2017 Mar;26(2):358-367
pubmed: 28244717
Glob Health Action. 2016 Oct 18;9:31704
pubmed: 27760677
Public Health Nutr. 2018 Jun;21(8):1426-1434
pubmed: 29493476
Obes Rev. 2013 Nov;14 Suppl 2:21-8
pubmed: 24102801
Can J Diabetes. 2018 Apr;42 Suppl 1:S130-S141
pubmed: 29650085
PLoS One. 2015 Nov 17;10(11):e0143050
pubmed: 26575644
J Cardiovasc Nurs. 2002 Jan;16(2):17-23
pubmed: 11800065
PLoS Med. 2012;9(6):e1001242
pubmed: 22723746
Appetite. 2013 Mar;62:209-15
pubmed: 22561190
Diabetologia. 2020 Mar;63(3):537-548
pubmed: 31792574
Health Policy Plan. 2021 May 17;36(4):397-406
pubmed: 33367513
Circulation. 1999 Sep 7;100(10):1132-3
pubmed: 10477541
Lancet Glob Health. 2013 Dec;1(6):e339-49
pubmed: 25104599
Clin Med (Lond). 2013 Feb;13(1):27-31
pubmed: 23472490
Global Health. 2015 Jun 04;11:23
pubmed: 26040275
JAMA. 2004 Aug 25;292(8):927-34
pubmed: 15328324
Health Policy Plan. 2018 May 1;33(4):474-482
pubmed: 29447397
Can J Diabetes. 2018 Apr;42 Suppl 1:S54-S63
pubmed: 29650112
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Diabetes Res Clin Pract. 2015 Feb;107(2):203-23
pubmed: 25529849
Diabetes Care. 2001 Oct;24(10):1821-33
pubmed: 11574449
Glob Health Action. 2015 Nov 26;8:29088
pubmed: 26613684
J Adolesc Health. 2000 Aug;27(2 Suppl):52-6
pubmed: 10904207
J Nepal Health Res Counc. 2019 Nov 14;17(3):394-401
pubmed: 31735938
PLoS One. 2018 Mar 29;13(3):e0195086
pubmed: 29596495
Health Policy Plan. 2019 Nov 1;34(Supplement_2):ii45-ii55
pubmed: 31723964
BMJ Glob Health. 2017 Oct 23;2(4):e000473
pubmed: 29104770
Foods. 2020 Jan 28;9(2):
pubmed: 32012832
Prev Med. 1999 Dec;29(6 Pt 1):563-70
pubmed: 10600438
Diabet Med. 2007 May;24(5):451-63
pubmed: 17470191
Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):123-8
pubmed: 25635985
BMC Public Health. 2018 May 21;18(1):641
pubmed: 29783961
Public Health Nutr. 2005 Jun;8(4):357-65
pubmed: 15975180
Health Place. 2012 Sep;18(5):1034-41
pubmed: 22795498
Curr Diab Rep. 2016 Jan;16(1):9
pubmed: 26748793
Diabetes Care. 2005 Mar;28(3):626-31
pubmed: 15735199
Diabet Med. 2020 Mar;37(3):455-463
pubmed: 31797455
Ther Adv Endocrinol Metab. 2019 Dec 24;10:2042018819897046
pubmed: 31903180
Patient Educ Couns. 2014 Mar;94(3):417-22
pubmed: 24341962
J Nepal Health Res Counc. 2015 Jan-Apr;13(29):1-6
pubmed: 26411705
Diabetes Ther. 2020 Sep;11(9):1935-1946
pubmed: 32712902
Health Aff (Millwood). 2012 Jan;31(1):199-207
pubmed: 22232111
PLoS Med. 2014 Jan;11(1):e1001582
pubmed: 24409102
Nutr Rev. 2006 Feb;64(2 Pt 2):S62-4
pubmed: 16532901
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175

Auteurs

Achyut Raj Pandey (AR)

HERD International, Kathmandu, Nepal.

Krishna Kumar Aryal (KK)

Public Health Promotion and Development Organization, Kathmandu, Nepal.

Niraj Shrestha (N)

Abt Britain, Kathmandu, Nepal.

Dikshya Sharma (D)

Sambhav (Possible), Kathmandu, Nepal.

Jasmine Maskey (J)

Oxford University Clinical Research Unit, Lalitpur, Nepal.

Meghnath Dhimal (M)

Nepal Health Research Council, Kathmandu, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH